89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study
Linders, D. G. J., Deken, M. M., van Dam, M. A., Wasser, M. N. J. M., Voormolen, E. M. C., Kroep, J. R., van Dongen, G. A. M. S., Vugts, D., Oosterkamp, H. M., Straver, M. E., van de Velde, C. J. H., Cohen, D., Dibbets-Schneider, P., van Velden, F. H. P., Pereira Arias-Bouda, L. M., Vahrmeijer, A. L., Liefers, G. J., de Geus-Oei, L. F., Hilling, D. E.
Published in Cancers (13.10.2023)
Published in Cancers (13.10.2023)
Get full text
Journal Article
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
van Rossum, A.G.J., Kok, M., van Werkhoven, E., Opdam, M., Mandjes, I.A.M., van Leeuwen – Stok, A.E., van Tinteren, H., Imholz, A.L.T., Portielje, J.E.A., Bos, M.M.E.M., van Bochove, A., Wesseling, J., Rutgers, E.J., Linn, S.C., Oosterkamp, H.M.
Published in European journal of cancer (1990) (01.10.2018)
Published in European journal of cancer (1990) (01.10.2018)
Get full text
Journal Article
An evaluation of the efficacy of topical application of salicylic acid for the treatment of familial cylindromatosis
Oosterkamp, H.M., Neering, H., Nijman, S.M.B., Dirac, A.M.G., Mooi, W.J., Bernards, R., Brummelkamp, T.R.
Published in British journal of dermatology (1951) (01.07.2006)
Published in British journal of dermatology (1951) (01.07.2006)
Get full text
Journal Article
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study
van der Voort, Anna, Louis, Fleur M, van Ramshorst, Mette S, Kessels, Rob, Mandjes, Ingrid A, Kemper, Inge, Agterof, Mariette J, van der Steeg, Wim A, Heijns, Joan B, van Bekkum, Marlies L, Siemerink, Ester J, Kuijer, Philomeen M, Scholten, Astrid, Wesseling, Jelle, Vrancken Peeters, Marie-Jeanne T F D, Mann, Ritse M, Sonke, Gabe S, van Leeuwen-Stok, E., van Leeuwen, L., de Graaf, H., van Riel, J.M.G.H., Houtsma, D., Vrijaldenhoven, S., van der Velden, A.W.G., Peerdeman, A.L., van den Brink - Schimmel, R.J., Drooger, J.C., Imholz, A.L.Th, Dercksen, M.W., Oulad Hadj, J., Bakker, S.D., van der Wouw, A.J., Kerver, E.D., Bouma, G., van Schaik, C., de Boer, M., Mandigers, C.M.P.W., Koornstra, R.H.T., Smals, A., Rietbroek, R.C., van der Padt - Pruijsten, A., den Boer, M.O., Bos, H., Schiphorst, P.P.J.B.M., Vriens, B.E.P.J., van Rossum, Q.C., Tol, J., Hoogwerf - Kluft, D., Kruijtzer - Schimmel, C.M.F., Oosterkamp, H.M., Baas, I.O., Dietvorst, A.H.P., Davidis - van Schoonhoven, M., van Dijk, M.A.
Published in The lancet oncology (01.05.2024)
Published in The lancet oncology (01.05.2024)
Get full text
Journal Article
Tumor infiltrating lymphocytes predict benefit from TAC but not from ddAC in triple negative breast cancer in the randomized MATADOR trial (BOOG 2004-04)
van Rossum, A.G.J., Hoogstraat, M., Opdam, M., Horlings, H., Wessels, L., Kerkhoven, R.M., van Leeuwen - Stok, A.E., Oosterkamp, H.M., Kok, M., Linn, S.C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study
Linders, D. G. J, Deken, M. M, van Dam, M. A, Wasser, M. N. J. M, Voormolen, E. M. C, Kroep, J. R, van Dongen, G. A. M. S, Vugts, D, Oosterkamp, H. M, Straver, M. E, van de Velde, C. J. H, Cohen, D, Dibbets-Schneider, P, van Velden, F. H. P, Pereira Arias-Bouda, L. M, Vahrmeijer, A. L, Liefers, G. J, de Geus-Oei, L. F, Hilling, D. E
Published in Cancers (01.10.2023)
Published in Cancers (01.10.2023)
Get full text
Journal Article
Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial
Beije, N, Kraan, J, Taal, W, van der Holt, B, Oosterkamp, H M, Walenkamp, A M, Beerepoot, L, Hanse, M, van Linde, M E, Otten, A, Vernhout, R M, de Vos, F Y F, Gratama, J W, Sleijfer, S, van den Bent, M J
Published in British journal of cancer (14.07.2015)
Published in British journal of cancer (14.07.2015)
Get full text
Journal Article
Pregnancy and severe aplastic anaemia: causal relation or coincidence?
Oosterkamp, H M, Brand, A, Kluin-Nelemans, J C, Vandenbroucke, J P
Published in British journal of haematology (01.11.1998)
Published in British journal of haematology (01.11.1998)
Get full text
Journal Article
Comparison of MUC‐1 mucin expression in epithelial and non‐epithelial cancer cell lines and demonstration of a new short variant form (MUC‐1/Z)
Oosterkamp, Hendrika M., Scheiner, Linda, Stefanova, Maria C., Lloyd, Kenneth O., Finstad, Connie L.
Published in International journal of cancer (03.07.1997)
Published in International journal of cancer (03.07.1997)
Get full text
Journal Article
IDENTIFICATION OF PATIENTS WITH RECURRENT GBM THAT BENEFIT FROM BEVACIZUMAB
French, P., Erdem-Eraslan, L., Kros, J. M., Oosterkamp, H. M., Walenkamp, A. M. E., Beerepoot, L., Hanse, M., Buter, J., Honkoop, A., van der Holt, B., Vernhout, R. M., Sillevis Smitt, P. A. E., Taal, W., van den Bent, M. J.
Published in Neuro-oncology (Charlottesville, Va.) (01.07.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.07.2014)
Get full text
Journal Article
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
Tjan-Heijnen, Vivianne C G, van Hellemond, Irene E G, Peer, Petronella G M, Swinkels, Astrid C P, Smorenburg, Carolien H, van der Sangen, Maurice J C, Kroep, Judith R, De Graaf, Hiltje, Honkoop, Aafke H, Erdkamp, Frans L G, van den Berkmortel, Franchette W P J, de Boer, Maaike, de Roos, Wilfred K, Linn, Sabine C, Imholz, Alexander L T, Seynaeve, Caroline M, Kitzen, J.J.E.M., Strobbe, L.J.A., Kouwenhoven, E.A., van Dalen, T., van Overbeeke, A.J., Nuytinck, J.K.S., Arntz, I.E., Blaisse, R.J.B., Stockmann, H.B.A.C., Nijhuis, P.H.A., Veldhuis, G.J., Mastboom, W.J.B., van Riel, J.M.G.H., van Dam, J.H., den Boer, M.O., Agterof, M.J., de Roos, M.A.J., Roumen, R.M.H., van der Hoeven, J.J.M., Beeker, A., Koelemij, R., van Bochove, A., Madretsma, G.S., Siemerink, E.J.M., Guicherit, O.R., Vos, A.H., Nieuwenhuijzen, G.A.P., Kehrer, D.F.S., Valster, F.A.A., Tanis, B.C., van Voorthuizen, T., van der Velden, A.M.T., Hellingman, R.A., Vree, R., van Rossum-Schornagel, Q., Meerum Terwogt, J.M., van Leeuwen-Breuk, W.G., Haasjes, J.G., Davidis-van Schoonhoven, M.A., Vriens, E.J.C., Jagers, M., Muller, E.W., Schiphorst, P.P.J.B.M., van Groeningen, C.J., van Dijk, M.A., Janssens- van Vliet, E., Schepers, E.E.M., Merkus, J.W.S., van Diemen, N.G.J., van Doorn, R.C., Bosscha, K., den Toom, R., van der Velden, P.C., van Rossum, C.T.A.M., Oosterkamp, H.M., van Hillegersberg, R., Jas, B., Weernink, E.E.M., Ketel, J.M.A., Jansen, J.J., Maring, J.K., Govaert, M.J.P.M., Kamm, Y.J.L., Vleugel, M.M., Hovenga, S., de Boer, J., Potthoff, H., Sommeijer, D.W., van Dulken, E.J.
Published in The lancet oncology (01.11.2017)
Published in The lancet oncology (01.11.2017)
Get full text
Journal Article
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
Schneeweiss, A., Peretz-Yablonski, T., Nowecki, Z., Merot, J.-L., Pena-Murillo, C., Bachelot, T., Coudert, B., Nowecki, Z., Wardley, A., Puglisi, F., Montemurro, F., Hu, X., Gaafar, R., Li, H., Aktas, B., Tienghi, A., Miles, D., Lux, M., Menjon Beltran, S., Turner, N., Tong, Z., Boer, K., Horvath, Z., Susnjar, S., Matos, E., Garcia Estevez, L., Cruz, M., Bourgeois, H., von Schumann, R., Morales-Vásques, F., Voitko, N., Hicks, J., Barrett-Lee, P., Wheatley, D., Gozy, M., Latini, L., Barnadas Molins, A., Bratos, R., McCarthy, N., Kee, D., Artignan, X., Azribi, F., Jaafar, H., Augereau, P., Müller, V., Evron, E., Cascinu, S., El-Saghir, N., Ghosn, M., Oosterkamp, H.M., Kukulska, M., Levitt, N., Panwar, U., Rigg, A., Fein, L., Malik, L., Singer, C., Stoeger, H., Cedeño, M., Berdah, J.-F., Goncalves, A., Orfeuvre, H., Fried, G., Moscetti, L., Siddiqi, N., Arcediano Del Amo, A., McAdam, K., Dunn, G., Taylor, W., Hegg, R., Grosjean, J., Laplaige, P., Christensen, B., Zahm, D.-M., Inbar, M., Bonetti, A., van der Velden, A., van Warmerdam, L., Viñas Vilaro, G., Bachmeier, K., Beresford, M., Joffe, J., Nobre, A., Jiang, J., Padrik, P., Dohollou, N., Prulhiere, K., Ober, A., Alabiso, O., van de Wouw, A.J., Saadein, A., Abdelhafiez, N., Abulkhair, O., Llorente Domenech, R., Gil Raga, M., Rodriguez Sanchez, C., Torrego Garcia, J., Vicente Rubio, E., Jones, A., Alonso, I.
Published in Annals of oncology (01.10.2021)
Published in Annals of oncology (01.10.2021)
Get full text
Journal Article
Phase I study of vintriptol, a tryptophan ester of vinblastine
Oosterkamp, H.M, Vlasveld, L.Th, Wanders, J, Beijnen, J.H, van Tellingen, O, Dubbelman, A.C, Simonetti, G.P.C, Franklin, H.R, Vermorken, J.B, Ten Bokkel Huinink, W.W
Published in European journal of cancer & clinical oncology (01.01.1991)
Published in European journal of cancer & clinical oncology (01.01.1991)
Get full text
Journal Article
189PDTumor infiltrating lymphocytes predict benefit from TAC but not from ddAC in triple negative breast cancer in the randomized MATADOR trial (BOOG 2004-04)
van Rossum, A G J, Hoogstraat, M, Opdam, M, Horlings, H, Wessels, L, Kerkhoven, R M, van Leeuwen - Stok, A E, Oosterkamp, H M, Kok, M, Linn, S C
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Use of perfusion MR imaging for differentiation between tumor progression and pseudo-progression in recurrent glioblastoma multiforme
Heidemans-Hazelaar, C., Verbeek, A. Y., Oosterkamp, H. M., Van der Kallen, B., Vecht, C. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
O10.05 FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND FIRST RADIOLOGY REVIEW RESULTS
Taal, W, Oosterkamp, H M, Walenkamp, AME, Dubbink, HJ, Beerepoot, LV, Hanse, M, Buter, J, Honkoop, A, Boerman, D, Vos, FYF, Dinjens, WNM, Enting, R H, Taphoorn, MJB, van den Berkmortel, FWPJ, Jansen, R, Brandsma, D, Bromberg, JE, van Heuvel, I, Vernhout, R M, van der Holt, B, van den Bent, MJ
Published in Neuro-oncology (Charlottesville, Va.) (01.09.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.09.2014)
Get full text
Journal Article
Neisseria subflava biovar perflava peritonitis in a continuous cyclic peritoneal dialysis patient
Vermeij, C G, van Dam, D W, Oosterkamp, H M, Verburgh, C A
Published in Nephrology, dialysis, transplantation (01.06.1999)
Published in Nephrology, dialysis, transplantation (01.06.1999)
Get full text
Journal Article
Abstract P1-14-16: Weekly paclitaxel, trastuzumab, carboplatin is a highly effective neoadjuvant regimen in HER2-positive breast cancer: Results from the TRAIN-study
van Ramshorst, MS, van Werkhoven, E, Mandjes, IAM, Schot, M, Wesseling, J, Vrancken Peeters, M-JTFD, Rodenhuis, S, Oosterkamp, HM, Bos, MEM, Meerum Terwogt, JM, Linn, SC, Sonke, GS
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P5-14-03: Adjuvant dose dense doxorubicin-cyclophosphamide (ddAC) or docetaxel-AC (TAC) for high-risk breast cancer: First results of the randomized MATADOR trial (BOOG-2004-04)
van Rossum, AGH, Oosterkamp, HM, van Werkhoven, E, Opdam, M, Mandjes, IAM, van Leeuwen-Stok, E, van Tinteren, H, Kok, M, Imholz, ALT, Portielje, JEA, Bos, MMEM, van Bochove, A, Wesseling, J, Rutgers, EJ, Rodenhuis, S, Linn, SC
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article